|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09887 LEADS BIOLABS-B
Nominal 
67.600 -4.700 (-6.501%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 35,969 | -- | 177,255 | 0 | 8,865 |
| Cost of Sales | -- | -- | -- | -- | (3,185) |
| Gross Profit | -- | -- | -- | -- | 5,680 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 41 | -91.277% | 541 | (40,366) | (111,096) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (218,849) | 31.525% | (195,893) | (301,216) | (362,249) | |
| Taxation | (3,083) | -- | (15,526) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (221,932) | 33.378% | (211,419) | (301,216) | (362,249) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (20,332) | 1033.965% | (22,374) | (2,521) | (5,147) |
| Depreciation & Amortisation | 11,406 | 0.334% | 21,209 | 26,042 | 23,909 |
| Directors' Emoluments | -- | -- | -- | 41,450 | 17,215 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| EPS (cts) | -113.000 | 6.604% | -121.000 | -201.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.887) | (0.792) | -- |
| NBV per share ($) | 4.680 | -- | 6.364 | -- | -- |
| Remarks: | Real time quote last updated: 01/09/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -221,932 |
| %Change | 33.378% |
| EPS / (LPS) | RMB -1.130 |
| NBV Per Share (¥) | RMB 4.680 |